Forager Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oportun Financial
OPRT
|
+$12.6M |
| 2 |
Viemed Healthcare
VMD
|
+$4.06M |
| 3 |
MillerKnoll
MLKN
|
+$3.34M |
| 4 |
Hovnanian Enterprises
HOV
|
+$514K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Money Express
IMXI
|
+$15.1M |
| 2 |
Willdan Group
WLDN
|
+$10.5M |
| 3 |
Garrett Motion
GTX
|
+$5.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 49% |
| 2 | Financials | 23.98% |
| 3 | Technology | 13.99% |
| 4 | Healthcare | 13.03% |
| 5 | Industrials | 0% |
Similar funds
Forager Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Forager Capital Management held 12 positions worth $227M, up 11% from $205M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Forager Capital Management withdrew a net $10.2M in Q3 2025, closing 1 position and reducing 2 holdings. Its most notable exit was Willdan Group, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 49% of assets, down from 50% a quarter earlier, followed by Financials and Technology.
Against the trend, Forager Capital Management opened a new position in Oportun Financial worth $12.1M.
- Forager Capital Management's largest Q3 2025 buy was Oportun Financial: 1,957,588 shares worth $12.1M.
- Forager Capital Management added most to Viemed Healthcare in Q3 2025, an estimated $4.06M increase.
- Forager Capital Management's biggest Q3 2025 reduction was International Money Express, cutting an estimated $15.1M.
- Forager Capital Management fully exited Willdan Group in Q3 2025, selling an estimated $10.5M.
- Forager Capital Management's ten largest holdings make up 99% of its $227M portfolio in Q3 2025.
- Forager Capital Management opened 1 new position and closed 1 in Q3 2025.
- Forager Capital Management's portfolio value rose 11% quarter-over-quarter to $227M.
Based on Forager Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.